International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂ - Wikidata - wikimedia - TriplyDB

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

http://www.wikidata.org/entity/Q28298445

about

Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors?Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats Nephrotoxic effects of common and emerging drugs of abuse.Endocannabinoid signaling in female reproduction The therapeutic potential of cannabis and cannabinoids The endocannabinoid system, cannabinoids, and pain The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines Is lipid signaling through cannabinoid 2 receptors part of a protective system?G protein-coupled receptors in the hypothalamic paraventricular and supraoptic nuclei--serpentine gateways to neuroendocrine homeostasis CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease Anticancer mechanisms of cannabinoids Medicinal cannabis Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain Lysophosphatidylinositol Signalling and Metabolic Diseases Plant derived substances with anti-cancer activity: from folklore to practice Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis Why do cannabinoid receptors have more than one endogenous ligand?Chemical probes of endocannabinoid metabolism Endocannabinoids are Involved in Male Vertebrate Reproduction: Regulatory Mechanisms at Central and Gonadal Level Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system Monoacylglycerol lipase - a target for drug development?Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids Endocannabinoids as biomarkers of human reproduction Triphasic blood pressure responses to cannabinoids: do we understand the mechanism?The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment A Binding Site for Nonsteroidal Anti-inflammatory Drugs in Fatty Acid Amide Hydrolase Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1 NPS: Medical Consequences Associated with Their Intake

P2860

Q21090468-2E28C363-805F-4B2C-A723-9FD079D245B1 Q21093231-0F96582F-4F60-47AB-95DA-7306F41E71E7 Q21135310-05390B7E-80B8-49FB-B293-06A5646DAADB Q21203937-D4015438-2839-4805-96D9-6DD90028AC97 Q21558458-B7B915A4-E990-4DD0-B568-5946EBD4CC5C Q24599033-3C028403-5F8D-475E-92C5-B427EDE0CB71 Q24600806-8A6BF0D1-0EEE-46B6-9C59-7C6FED765761 Q24601890-DA4E1AE6-CC09-4ADC-8A15-4DA34CFDB104 Q24602845-635234FF-8FCA-491D-BC0C-967A80D38F1D Q24605072-A80FF71C-FFFF-4160-9651-6454DB8AF0CC Q24631675-494696AE-CB3A-4BDC-BE83-B17692EF18CE Q24633122-A14B0CC1-6515-40B0-8F2A-234E25E20E1B Q24633335-5A9B35D8-8918-452A-92A8-CBF69056837F Q26746050-18E3F707-2FFB-49AB-8F21-D13152A4E69D Q26750399-448ED8D7-CB4D-4B38-8938-3921D22A212C Q26769626-B161FE1C-4DD8-4CD8-BCB9-55F5C54D9299 Q26769951-5C44EEF8-29CE-4B3B-860B-0248600B6CBC Q26771102-678C0C8F-42F5-4642-8A28-A556194D2C76 Q26781498-E0899410-1463-41D9-9E25-371D7C0A67E0 Q26783956-7C574BDB-CF79-41C6-B187-6AF0E4C7CDE1 Q26862444-99FF1216-54F2-41FA-A2E1-E5D353819F1A Q26863202-D88A3BAE-4534-46F1-885F-F355E0DF7A83 Q26864201-32358225-98A3-4012-A9D8-7DF705E91A3F Q26865295-E889C795-9514-4F60-BC4D-834229582756 Q26998964-4C53EAB6-A629-4E92-94E1-9B23128A3342 Q27005619-ED1EF401-559C-4F23-B002-2DC957D22B40 Q27010555-FC51D5A5-2DFD-4ABC-A1D4-CF9FE109E88A Q27024033-F96B43B1-7D64-4D6E-B341-443E9E6B8B3A Q27025612-034AFBAB-A658-4442-A1E2-8874FE33741B Q27026491-94B9C54B-3419-457A-9B38-96EB84305EE8 Q27306768-E33D8D99-5577-4FDF-9297-94B2DDC0ADBD Q27324350-1259C4E1-D0C2-432D-B29A-BED0375F09D4 Q27675504-2115240F-8363-4DEE-A278-1D3F64D43646 Q28066215-B35011F0-5A75-4C65-B534-D4C895FD7FF9 Q28072822-1DD53B91-5098-4437-909F-955613DF2AE1 Q28078897-6226643F-419E-4C49-B500-A9B66C81DF35 Q28236199-09DBDE35-7328-4FF4-A497-4C7E04E150B3 Q28238141-E74A9B55-AEA3-40B4-B9CE-0E3D7CB459BC Q28245037-E911E21E-7EA8-4BF0-BE95-FD2DE4439A5A Q28276182-D10AB949-154A-4B28-ABC3-6D3286FA7AA3

P2860

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂

http://www.wikidata.org/entity/Q28298445

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@ast

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@en

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@nl

type

label

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@ast

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@en

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@nl

prefLabel

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@ast

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@en

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@nl

P1433

Q28298445-1F6915B1-D8C6-4AAF-8256-6EDEE6CB6E10

P1476

Q28298445-DC58999A-832C-4E21-8DA9-E139C720504A

P2093

Q28298445-063A2DE2-3056-49C9-8CE7-D47374351E12

Q28298445-167F73C2-4BCD-4120-830D-37F4649CB934

Q28298445-1723A03C-1992-4010-A8AD-2ACDEFA9F2D6

Q28298445-696E0C93-B046-4B05-926E-C23D8A8CF778

Q28298445-8A6D8501-8DD1-44F1-A228-C6391319FA10

Q28298445-9FB07684-D54A-4389-ABBE-B109A298319C

Q28298445-AEA3AD74-591B-417E-A8D3-A3CAD56CFD54

Q28298445-C6D77F91-913B-459E-9670-17A622E49227

Q28298445-D238288A-2D3E-45AC-9BF1-6439DA623D99

Q28298445-F66B1881-D7FC-4E49-B3A6-599A4C7B75D3

P2860

Q28298445-022461A9-B47D-4FB4-AC0F-699E0E56ACE3

Q28298445-029D36BA-BDBA-4398-92EE-8460CA28AD57

Q28298445-03AA545B-D924-470B-8874-E623543500F9

Q28298445-03AC319E-2244-4675-9237-8321911F3C77

Q28298445-056D4AEA-798D-4EB4-9C34-384272ECF612

Q28298445-0624E756-918E-4B88-B1F1-CA93B83BE064

Q28298445-06A3CE57-A85F-4A1E-89C2-E3F48A9AB41B

Q28298445-06A7DCB2-F468-482A-BA1A-6C90C97D01AC

Q28298445-06EE2EE5-9CC1-4F40-A009-391277FF9D09

Q28298445-07BB878D-DA9E-468F-8C34-FA03AED32106

P304

Q28298445-20E8A15E-67AD-4FD6-B4C7-3B79AA6ACF15

P31

Q28298445-1060B1E0-FE96-4581-81DF-E7919D600AFE

P3181

Q28298445-1B33745D-665B-43E1-9B26-975B0842D089

P356

Q28298445-A7133C29-CA87-4792-8AE2-7948309471F1

P407

Q28298445-430243D0-0AC3-4A12-A17D-5BA3ADA3AF81

P433

Q28298445-32FE8634-9794-44E4-BAE5-6E34ABF9DD84

P478

Q28298445-3FFDF9CC-04AB-4A32-923C-B2E068E3548B

P50

Q28298445-979B7575-5703-4FBA-BFBC-DFF4BCC2C9D7

Q28298445-9BE2DD11-DA46-48DE-B0CE-10C0239E4870

P577

Q28298445-6988FC33-E95E-4B06-A251-015EAE68A478

P5875

Q28298445-9B18D17C-F9EB-42F8-83E2-D52A7E03D881

P698

Q28298445-5587EE2F-C34E-42D2-82CC-45A50BA3408C

P921

Q28298445-1C08C975-4681-4EC2-9341-CC9DAFFF21D8

Q28298445-984acd2d-f293-4da4-90c0-7c688e1141e3

Q28298445-CBC59F70-A02A-4EF3-8697-5A7E67937345

Q28298445-DA8124BB-92B8-42AA-8EE6-9DA654F4E2CA

P932

Q28298445-19B3D928-B9B0-45A3-840C-210A6647A33B

P3181

P356

P1433

Pharmacological Reviews

P1476

International Union of Basic a ...... ir ligands: beyond CB₁ and CB₂

@en

P2093

A C Howlett

http://www.w3.org/2001/XMLSchema#string

G Kunos

http://www.w3.org/2001/XMLSchema#string

H S Hansen

http://www.w3.org/2001/XMLSchema#string

M E Abood

http://www.w3.org/2001/XMLSchema#string

M R Elphick

http://www.w3.org/2001/XMLSchema#string

P J Greasley

http://www.w3.org/2001/XMLSchema#string

R A Ross

http://www.w3.org/2001/XMLSchema#string

R G Pertwee

http://www.w3.org/2001/XMLSchema#string

S P H Alexander

http://www.w3.org/2001/XMLSchema#string

V Di Marzo

http://www.w3.org/2001/XMLSchema#string

P2860

Initial sequencing and analysis of the human genome

N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor

How cold is it? TRPM8 and TRPA1 in the molecular logic of cold sensation.

Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation

Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands

Cloning and chromosomal localization of a gene (GPR18) encoding a novel seven transmembrane receptor highly expressed in spleen and testis

G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth

Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42

Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha

P304

588-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

688713

http://www.w3.org/2001/XMLSchema#string

P356

10.1124/PR.110.003004

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

Raphael Mechoulam

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47794388

http://www.w3.org/2001/XMLSchema#string

P698

21079038

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

P932

2993256

http://www.w3.org/2001/XMLSchema#string